TIL therapy for advanced uveal melanoma and sarcomas
Treatments studied
Part of Cancer, Eyes & vision, Skin clinical trials.
This trial tests using your own immune cells (TILs) to fight advanced uveal melanoma, undifferentiated pleomorphic sarcoma, dedifferentiated liposarcoma, or angiosarcoma. It aims to see if this treatment can shrink tumors or slow their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have one of these cancers that has spread or cannot be removed surgically.
- You need at least one tumor that is 1.5 cm or larger and can be removed for the TIL manufacturing.
- You must have recovered from any side effects of prior cancer treatments before starting the study.
- You must be 18 or older and in reasonably good health, with a life expectancy of at least 6 months.
- Blood and organ function tests must meet certain thresholds (your doctor will check these).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment using your own immune cells to fight advanced melanoma. The cells are taken from a tumor, grown in a lab, and given back to you either near the tumor or throughout your body.
This trial tests a new way to treat advanced melanoma by taking immune cells from your tumor, enhancing them in the lab to fight better, and giving them back to you. It is for people whose melanoma has spread or cannot be removed, and who have already tried standard treatments.
This trial tests a treatment that uses your own immune cells, called tumor-infiltrating lymphocytes (TILs), to fight melanoma. Some participants also get a drug called pembrolizumab. The goal is to see if this approach can shrink tumors.
This study uses your own immune cells (called TILs) to fight melanoma that has spread to the liver. Doctors will remove a piece of the tumor, grow the immune cells in a lab, and give them back to you to help shrink the cancer.
This trial tests a treatment made from your own immune cells (called tumor-infiltrating lymphocytes). The cells are taken from a tumor sample, multiplied in a lab, and given back to you to help fight the cancer. It's for people with melanoma that has not responded to standard immunotherapy.
This Phase 1 study tests LM103 to treat advanced cancers that are not responding to standard treatment. It also looks at whether enough tumor tissue can be collected for immune cell testing, and focuses on safety at first.
Hear when a new Uveal Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.